Background: Diagnosis based on prion detection in lymph nodes of sheep and goats can improve active surveillance for scrapie and, if it were circulating, for bovine spongiform encephalopathy (BSE). With sizes that allow repetitive testing and a location that is easily accessible at slaughter, retropharyngeal lymph nodes (RLN) are considered suitable organs for testing. Western blotting (WB) of brain homogenates is, in principle, a technique well suited to both detect and discriminate between scrapie and BSE. In this report, WB is developed for rapid diagnosis in RLN and to study biochemical characteristics of PrP res .
Background
Transmissible spongiform encephalopathies (TSEs) or prion diseases are fatal diseases of the central nervous system, characterized by long incubation periods before neurological symptoms appear. TSEs were initially described in sheep as a transmissible disease named scrapie, and in man, as Creutzfeldt-Jakob disease (CJD), a sporadic disease with no detectable link between cases. The diseases can be diagnosed by vacuolation of neurons in the brain and appearance of a structurally altered form of the host encoded prion protein (PrP), termed PrP Sc . TSEs represent a unique class of infectious diseases in which PrP Sc is considered to be the transmissible agent [1] [2] [3] .
TSEs have attracted much attention since bovine spongiform encephalopthy (BSE) was first described in the 1980s [4] . The more or less accepted explanation for the appearance of this condition was the capacity of the scrapie-like agent to spread to cattle fed with insufficiently heated remains of ruminants [5] . In the 1990s a new form of CJD was observed affecting mainly young people [6] . This so-called variant CJD is considered to be caused by the BSE agent [7] and to have spread by the consumption of infected food containing residual bovine nervous tissues, although other means of transmission, such as the use of ruminant-derived substances in medical products, can not be ruled out. Furthermore, man-to-man transmissions might have occurred subsequently by blood transfusions. BSE is now largely under control, but two recent reports describing goats with BSE have strengthened the fear that the BSE agent could again become widespread in some food animals before being diagnosed [8] [9] [10] . In order to prevent this from happening, the TSEs from livestock must be eradicated. For this purpose a number of programmes are underway.
For eradication of ruminant TSEs in Europe, where BSE cases have occurred in nearly all member states, control programmes have been implemented (EU legislation 999/2001 and additions), e.g., the removal of risk materials, active monitoring of slaughtered cattle, sheep and goats, stamping out of scrapie, and genetic breeding of sheep towards scrapie and BSE resistant PrPgenotypes. Active monitoring is possible using brain tissue taken late in the incubation phase. Early diagnosis of TSEs can assist in monitoring programs and has potential in sheep and goats where lymphoreticular tissues generally accumulate infectivity and aberrant PrP [11] [12] [13] [14] . Indeed, until now, tonsil and other lymphoid tissues have been targets for preclinical scrapie diagnosis in sheep, making reliable diagnosis possible in biopsies early during incubation [15] [16] [17] . However, for the diagnosis to be as early as possible, i.e. in the preclinical stage, diagnostic methods more rapid than the time consuming microscopic and bioassay techniques currently employed are required. Such a diagnosis should also preferably allow discrimination between TSE strains like scrapie and BSE, as is described for Western blotting (WB) methods applied to brain [18] [19] [20] [21] [22] .
A very reliable indicator of disease is the presence of abnormal forms (PrP Sc ) of prion protein. It is recognized by immunohistochemistry (IHC) as accumulations of PrP, or as a partially protease-resistant protein (PrP res ). By WB of PrP res using PrP-specific antibodies, a typical triplet banding pattern appears, representative of diglycosylated, monoglycosylated and aglycosyl PrP res moieties, migrating with apparent molecular masses between 16 and 30 kDa. Using staining with two antibodies specific for different PrP-sites, WB can even discriminate between scrapie and experimental BSE infection in sheep brain due to differential cleavage of PrP res by proteinase K (PK) [21, 22] .
In this study we investigated the applicability of PrP res WB to retropharyngeal lymph nodes (RLN) since these organs are easily accessible at slaughter and are one of the best targets for diagnosis in the lymphoid system [13, 17, 23] 
Results

Antibody choice and fine epitope specificity
In lymphoid tissues PrP res concentrations have been reported to be 20 times lower than in brain [24] . Therefore, monoclonal antibodies (mAbs) with superior affinity for ovine PrP in Western blot (WB) were sought. Ten mAbs (SAF84, SAF70, P4, L42, 8G8, 34C9 6H4, 94B4, 12B2 and 9A2) with specificity for ovine PrP were compared on WB strips by varying two parameters: mAb concentration and amounts of ovine scrapie brain digest (see Methods section). As a result, antibodies 12B2, P4, 9A2, and L42 were selected as the most reactive. The epitope specificities of these four mAbs were determined by Pepscan analysis on solid phase synthetic ovine PrP peptides ( Figure 1 ). Synthetic peptides carrying these epitope sequences were also used in solution to investigate by ELISA their capacity to block binding to recombinant ovine PrP. Indeed, as can be expected for antibodies that are elicited with peptides, all four of these could interfere effectively with antibody binding to PrP, confirming the significance of the mapped specificities (Table 1) .
Tissue treatment and choice of retro-pharyngeal lymph node A practical means of homogenisation was chosen for tonsillar and medial retropharyngeal lymph node (RLN) tissue by using disposible homogenisers available for mass screening purposes. Prypcon homogenisers were preferred since these consistently yielded satisfactory suspensions while other probes caused formation of gel in the homogenate.
Homogenates of tonsils and RLN from scrapie-infected sheep were examined after enzymatic hydrolysis with proteinase K (PK) and/or deglycosylation with PNGaseF (Figure 2) . Digestion with PK resulted in the typical triplet of diglycosylated, monoglycosylated and aglycosyl PrP res . Subsequent removal of carbohydrate moieties by PNGaseF led further to a prominent single deglycosylated PrP res band. There were no major differences in PrP immunostaining between tonsils and RLNs.
In further studies, RLN tissue was used as the preferred tissue for evaluating lymphoid tissues, since in contrast to tonsillar tissue, it lead to reproducible scrapie diagnosis and organ size was large enough for repetitive analysis. This better reproducibility is likely due to a more homogeneous distribution of PrP Sc in RLN compared to tonsils. Also, at slaughter, RLNs are more easily accessible in the decapitated head than are tonsillar tissues.
Diagnosis of scrapie in sheep during the incubation phase
We wished to know first, whether WB could detect scrapie in the preclinical phase. As reported previously, VRQ/VRQ sheep from our scrapie-infected flock are IHC positive in tonsils and RLN at two months of age [25, 26] . RLN samples of 18 such sheep, as well as of 6 scrapie negative sheep (4 VRQ/ARR and 2 ARR/ARR genotypes), were examined by WB. From the age of three months, WB yielded results identical to IHC (Table 2 ). In 2-month old cases, WB was negative, whereas IHC could detect PrP only in fewer than 25% of the follicles. From the age of four months onwards, all VRQ/VRQ sheep were positive in both IHC and WB. A 20-fold concentration step allowing application of 20 mg tissue equivalents (TE) per lane instead of 1 mg yielded a proportionally stronger signal in the positive cases, but did not change the diagnostic outcome (data not shown). The RLN samples from the 6 scrapie negative sheep remained WB negative. [22, [27] [28] [29] [30] [31] . These results also emphasize that for discrimination between scrapie and BSE in dual antibody staining, the use of core antibody L42 is preferable to 9A2, especially in weakly positive samples.
Diagnosis of scrapie in field cases from surveillance and with mostly unknown ages
RLNs from sheep with various PrP genotypes and from different sources, were examined by WB and IHC. In general, again, there was a good correlation between the two methods, since divergent results occurred only for some weak IHC-positive cases (Table 4 ; and for individual data see Table 10× concentration factor, but the diagnostic result in this set of samples was the same as found for the unconcentrated samples.
Molecular weight and glycoprofiles of PrP res bands
Apparent molecular weights (MW r ) of the three PrP res bands in WB of RLN digests were compared for a correlation by type of infection (scrapie or BSE), stage of incubation or genotype. A BSE-specific difference in the MW r existed and was especially distinct for the aglycosyl moiety, which was about 1kDa larger in scrapie samples than in BSE samples (Table 5 ). This appeared to be the case for both antibodies 9A2 and L42. Antibody 12B2 (and P4, not shown) only bound well to the scrapie-infected samples ( Figure 3 ) indicating that, as in brain stem tissue [22] , a discrimination between scrapie and BSE by dual WB staining is possible using lymphoid tissues, i.e. comparing the immunostaining of a sample for PrP-core specific antibody (e.g. 9A2 or L42) and PrP res N-terminus specific antibodies (12B2 or P4). However, no marked differences in MW r for the PrP res bands (not shown) were observed between preclinical and clinical stages of incubation or between scrapie sheep with different genotypes.
Glycoprofiles found in individual RLN samples are presented on a triangular graph which allows visualisation of the relative concentration of all three PrP res bands, i.e., the di-, mono-, and aglycosyl moieties ( Figure 4 ). The apparent variations in glycoprofile were further analyzed for correlation with TSE-type, TSE-incubation stage, and genotype. Firstly, for the TSE-types, the diglycosyl fraction of PrP res in scrapie samples of the surveillance group and preclinical study were around 54% (range , while in BSE-infected sheep in the preclinical and clinical phases, respectively, it constituted 64% (range 58-68) and 74% (range 69-82). These 3 values were significantly different from each other (P < 0.001), and similarly, the aglycosyl and monoglycosyl fractions were statistically different [33, 34] . Detection of BSE PrP res by WB in RLN of ARQ/ARQ sheep was possible at 6 months post-infection (pmi), the earliest stage investigated, and in all other animals at later stages. The diag- nostic score by WB in our BSE-study on RLN was nearly similar as to that obtained by IHC, except for the animal with shortest incubation (6 mpi, (Table 2) , WB might have missed positive diagnosis in 4 preclinical cases, since these analyses possibly obex parts lacking dorsal motor nucleus of the nervus vagus where the first positivity can be found [25] . In our hands the PrP Sc precipitation technique described by Wadsworth [24] , which is based on the presence of phophotungstic acid, gave unsatisfactory recoveries (≤ 60%) after PK digestion. Recoveries were much better if precipitation preceded PK digestion, but this approach changed the mobility of the PrP res bands, making it difficult to rely on molecular weight determination to distinguish between strains.
When analysed by WB, glycoprofiles and apparent molecular weights of PrP res in RLN digests were similar to those reported for brain tissue of scrapie or BSE infected sheep [22] . This means firstly, that, using RLN, both TSEs can be detected in a single screening with the PrP-core specific antibodies L42 or 9A2. Secondly, differentiation of BSE and scrapie can be done subsequently, in a dual antibody test using two blots, one with a PrP-core specific antibody, such as L42 or 9A2, and the other with a PrP res N-terminus specific antibody, such as P4 or 12B2. All these antibodies have high affinity for ovine PrP. Glycoprofile analyses can further support the differential diagnosis of scrapie and BSE, where the relative amount of the diglycosyl moiety of PrP res is lower in scrapie than BSE. However, glycoprofiling remains an inconclusive tool in discriminating scrapie from BSE cases since there is overlap in glycoprofile between the scrapie and BSE cases (Figure 4) . In other studies glycoprofile analyses in sheep have yielded too divergent results in scrapie cases to allow a discriminatory diagnosis between scrapie and BSE [18, 20, 50, 51] . Nevertheless, the relatively high concentration of the diglycosyl PrP res fraction in BSE-infected animal species, including humans with a variant form of Creutzfeldt-Jakob disease, remains noteworthy [21, [52] [53] [54] . A new factor in glycoform analyses of PrP res is the possible dependence on stage of incubation. Though this was not statistically significant, it was striking that in both our sheep TSE incubation studies, experimental BSE in ARQ/ARQ sheep and natural scrapie in VRQ/VRQ animals, a correlation was found, revealing an age dependent increase in the diglycosyl moiety of PrP res with a concomittant decrease in the a-and monoglycosyl fractions. This association was not due to a technical artifact since no correlation between glycoprofile and concentration of PrP res . These time-related variations in protein glycosylation could be due to disease status, but normal age dependent variations in posttranslational processes during protein synthesis should also be considered [55] . Finally, these glycoprofile variations further indicate that, as a tool for discriminating scrapie from BSE, glycoprofiling in sheep is a rather unreliable parameter when the age of the animal and the strain properties of the isolate are not known. Likewise, in brain, further studies are needed to establish a time-dependent relation of PrP res -glycosylation.
This study was performed on samples collected during the years 2002-2003 and appears to be a rather representative cross-section of the Dutch sheep population, with respect to the presence of the different genotypes (compare for the years 1999-2001 in [22] ). It remains to be seen how consistently the RLNs score in different age groups, genotypes and preclinical stages. Nevertheless, the efficacy of detecting scrapie and BSE infection in current monitoring programs can be highly improved for animals in a stage where the TSE agent has not yet invaded the central nervous system, i.e., at ages younger than 18 months. At older ages, both brain and RLN testing is needed to optimally assure absence of TSE. It is expected that lymphoid testing also enhance surveillance efficiency in goats, where the lymphoid system usually is involved [11, 14, 56] (Van Keulen personal communication).
Conclusion
This study demonstrates that Western blotting can be used for routine screening of classical scrapie and BSE in retropharyngeal lymph nodes of sheep at slaughter with a sensitivity nearly the same as immunohistochemistry. A concentration step for PrP res is required. The difference in polypeptide length of PrP res between BSE and scrapie can be unequivocally confirmed by dual antibody staining using two classes of antibodies: one which binds to the Nterminus of PrP res in scrapie only, and one which binds to the core of PrP res in both BSE and scrapie.
Methods
Sheep and tissues
Sheep used were from our own flock, from slaughter or fallen stock. In total, 103 sheep were used in this study.
For preclinical and clinical scrapie, 24 animals with known ages were used (Table 2 ). These animals have been described previously in immunohistochemical (IHC) pathogenesis studies [25, 26] and were bred within our own Texelcross flock with natural scrapie. The animals were euthanized and sampled at ages from 2-26 months. 18 sheep were of VRQ/VRQ genotype. Potentially negative controls from the same flock comprised 4 ARR/VRQ (ages 17, 17, 24, and 24 months) and 2 ARR/ARR animals (ages 3 and 6 months).
For preclinical and clinical BSE, 11 sheep of ARQ/ARQ genotype were orally fed with bovine BSE brain as previously described [27] . Four of these animals were kept until clinical signs of disease appeared, the others were euthanized between 6 -19 months post-infection. These animals were positive by IHC for PrP Sc in their tonsils at biopsy or at autopsy ( Table 3 ).
The remaining 68 sheep were from different surveillance sources, most of them of unknown ages (see for individual data Table in "additional file 1"). Within this group, 12 animals with and without clinical suspicion of scrapie were obtained from either our own flock with natural scrapie (n = 5), our own flock maintained with minimal scrapie-incidence (n = 3), private farms with clinically suspect cases (n = 3), or a private farm with known history of scrapie (n = 1, normal animal). Of the remaining sheep, most were diagnosed through the active surveillance program for slaughter (n = 50) and fallen stock (n = 6). The heads of the animals in the monitoring program had been kept at 4°C for up to three days. Seven of the 68 animals were TSE negative in the brain by rapid testing and IHC, with one of these 7 being TSE positive in tonsil and RLN by IHC.
Brain and lymphoid tissues were collected for IHC and biochemical assays. From brain, one parasagitally cut longitudinal half was fixed in formaldehyde and embedded for pathological and immunohistochemical analysis [25] ; the other smaller part was stored at -20°C. Lymphoid organs from one side of the animal were sampled for IHC, and from the other side were stored at -20°C for biochemical assays.
Scrapie diagnosis
The Prionics-Check Western blot method for active monitoring of BSE in cattle was used [57] for routine scrapie diagnosis on brain stem at the obex region. This method uses digestion with proteinaseK at 50°C and PrP-specific monoclonal antibody 6H4 for detection. Scrapie was further confirmed by immunohistochemical (IHC) analysis on brain and lymphoid tissues according to established procedures with the various antibodies described and characterized previously [13, 27, 58] .
Genotyping
Blood from sheep were used for PrP genotyping for PrP codons 136, 154, and 171 using two genotyping techniques, i.e., TaqMan analysis and, for confirmation of Arg, Gln or His at codon 171, Pyrosequencing [22, 44] . To exclude mistakes by exchange of samples, genotype was also checked in homogenates of RLN and brain stem.
Antibodies and fine epitope mapping by Pepscan analysis, peptide synthesis and blocking ELISA Antibodies used for WB were from different sources. The following murine PrP-specific monoclonal antibodies (mAbs) were purchased: P4, L42 (R-Biopharm, Almere, The Netherlands), 8G8, SAF70, SAF84 (SPI-BIO, Montigny le Bretonneux, France), 34C9 and 6H4 (Prionics AG, Zurich, Switzerland). These mAbs were prepared as described [59] [60] [61] [62] . MAb 94B4 was previously described [22] and mAbs 12B2 and 9A2 were newly prepared using PrP-knockout mice [63] immunized with peptide GGGGWGQGGTHGQWNKPSK (bovine PrP 97-115), conjugated through a cysteine at its Cterminus to Keyhole limpet hemocyanine using previously described procedures [64] . Immunisations were carried out in the presence of incomplete Freund's adjuvant (first injection) or adjuvant CoVaccine HT (CoVaccine, Utrecht, The Netherlands) in 4 administrations evenly distributed over a period of 63 days. Animals were bled and spleens used for hybridisation to Sp2/0 myeloma cells according to standard procedures. Screening for PrP-specific antibodies in sera and culture supernates was performed by indirect ELISAs using the peptide, recombinant ovine PrP (kind gift of T. Sklaviadis, Aristotle University, Thessaloniki, Greece) and bovine PrP (Prionics AG) as coated antigens at 0.2, 0.2, and 0.1μg/ml, respectively. The fine epitope specificities of 12B2, 9A2 and L42 were determined by Pepscan analyses with overlapping 15-mer solid phase peptides using the ovine PrP sequence as sequence basis as previously described [22, 65] , and further confirmed in ELISA by blocking antibody binding to coated recombinant ovine PrP, using synthetic peptides. Blocking ELISA was performed as follows: polystyrene microtiter plates were coated overnight at 4°C with recombinant ovine PrP at 0. , and heating for 5 min at 95°C. On some occasions, concentration of PrP res in RLN was first carried out by centrifugation of 100 μl digest in 1.5 ml vials at 14,000 rpm, 21,000 xg for 1 h in an Eppendorf 5417R centrifuge at 4°C as recently described [66] ; pellets were dissolved by subsequent addition of 10 μl 0.1 % N-lauroylsarkosine in PBS and 10 μl of 2× sample buffer. Samples were heated for 5 min at 95°C.
Brain stem tissue from scrapie sheep was homogenized and digested either according to the protocol of a routine test (PrionicsCheck) or treated as above for RLN. To enhance sensitivity, PrP res was concentrated as follows: after digestion with PK and addition of Pefabloc, the digest was mixed with 100 μl of a mixture of propan-2-ol/ n-butan-1-ol (1/1, v/v) and centrifuged for 5 min at 21,000 xg in a microcentrifuge at room temperature (Eppendorf). The pellet was finally dissolved in 1× sample buffer (2 × sample buffer diluted with an equal volume of water). The recovery of PrP res in this procedure for concentration was consistently >90% when comparing equal tissue equivalents of unconcentrated and concentrated material, allowing the application of 20 mg tissue equivalents (TE) per lane, instead of 1 mg TE in unconcentrated state. This concentration method employed the protein precipitating properties of alcohols while removing SDSPAGE-disturbing components from brain tissue.
Deglycosylation treatment with PNGaseF
Removal of asparagine-linked oligosaccharides after PK digestion was performed as follows, After blocking the PK reaction with Pefabloc, 10 μl of denaturation buffer (5% sodium dodecyl sulfate [SDS], 10% β-mercaptoethanol in 20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA [pH 7.5]) was added to the sample. This was heated for 10 min at 95°C. After cooling, 10 U of PNGaseF (New England Biolabs, Beverley, USA) was added and incubated overnight at 37°C. To stop the reaction, 100 μl of 2× sample buffer was added and the mixture heated for 5 min at 95°C. 
SDS-PAGE
Statistical analyses
One-way analyses of variance (ANOVA) were carried out to establish whether variations between groups of data, in casu glycoform fractions of PrP res , were greater than expected; if so, subsequent differences between pairs of groups were considered significant if the probability of a difference was <0.05 in multiple-comparisons tests according to the Student-Newman-Keuls test. Linear regression analyses were performed for an increasing or decreasing trend with disease incubation on data obtained in preclinical scrapie and experimental BSE infection study using a P value of <5% as confidence interval for concluding that the data are unlikely to be sampled from a population in which the slope is zero. The linearity of these curves could not be reliably established due to the small number of samples. The software used for these calculations was Instat Biostatistics from Graph-Pad Software, San Diego, CA.
